MyPeptideHelper

Healing & repair

BPC-157

Limited human data

Extensive animal data on tendon, ligament and gut healing.

SubQOralBeginnerNot approved anywhereinjury repairgut healthjoint and tendon healthinflammation

Also known as Body Protection Compound 157 · PL 14736

At a glance

Dose summary

Typical dose250 mcg
Range200 mcg–500 mcg
FrequencyDaily
Half-life~4 h
ScheduleOnce daily
Cycle length8 weeks
RouteSubQ · Oral
Experience levelBeginner
Evidence gradeLimited human data
ApprovalNot approved anywhere
Where the dose comes fromCommunity practice, not a trial

No regulator and no trial set these numbers. They describe what people actually do, recorded so you can see the range rather than guess at it — which is not the same thing as a recommendation.

Reconstitution

What to draw, at the usual vial

A 5 mg vial reconstituted with 2 mL of bacteriostatic water gives 2.50 mg/mL. A typical 250 mcg dose is 0.100 mL — pull the plunger to 10 units on a U-100 syringe.

Concentration2.50 mg/mL
Draw volume0.100 mL
U-100 units10 units
Doses per vial20

Same dose, other vial sizes

VialWaterConcentrationDrawUnitsDoses
5 mg2 mL2.50 mg/mL0.100 mL10 units20
10 mg2 mL5.00 mg/mL0.050 mL5 units40

The highlighted row is the one quoted above: the smallest listed vial that holds at least four typical doses. Change any of it — a different vial, more or less water, a different dose — on the reconstitution calculator, which draws the syringe to true U-100 graduations.

Mechanism & evidence

What it is, and what is known

Extensive animal data on tendon, ligament and gut healing. Human trial data is limited and it is not an approved medicine in the US.

The caveat

Extensive animal data; the human trial record is thin.

Tolerability

Reported side effects

  • Injection site irritation or redness
  • Mild nausea, usually transient
  • Light-headedness in some users

Hard stops

Do not use this if

  • Pregnancy, possible pregnancy, or breastfeeding
  • Active, suspected or recently treated malignancy

These are flags, not a screening. They do not replace a conversation with a clinician who knows your history.

Handling

Storage

Sealed powder, refrigerated24 months
After reconstitution, refrigerated30 days

Keep it cold, keep it dark, and label the vial with the date you mixed it. Discard anything cloudy or past the window above.

Combinations

Commonly stacked with

TB-500Animal data onlyHealing & repairKPVAnimal data onlyHealing & repairGHK-CuLimited human dataCosmetic

Stacking multiplies the side-effect surface and makes it impossible to tell which compound did what. Add one thing at a time.

Where it shows up

Protocols using this compound

KLOW250 mcg · once dailyA fixed four-peptide healing blend sold in a single vial: GHK-Cu, BPC-157, TB-500 and KPV. It is the older GLOW blend (GHK-Cu + BPC-157 + TB-500) with KPV added, which is where the leading K comes from. Run as one daily subcutaneous shot for soft-tissue repair, gut and skin work.GLOW 42200 mcg · once dailyA fixed three-peptide repair and skin blend sold in a single 42 mg vial: GHK-Cu, BPC-157 and TB-500. This is the original GLOW blend, and it is exactly KLOW with the KPV left out - KLOW is GLOW plus KPV, which is where the leading K in KLOW comes from. Run as one daily subcutaneous shot for skin, soft tissue and connective tissue work.Wolverine Stack500 mcg · once dailyThe classic two-peptide repair stack: BPC-157 daily for local tendon, ligament and gut healing, plus TB-500 loaded twice weekly for systemic cell migration and tissue remodeling. The most commonly run injury protocol and the base that KLOW was built on top of.Retatrutide + KLOW250 mcg · once dailyA fat-loss block that pairs weekly retatrutide with the daily KLOW healing blend. The logic people give is that aggressive weight loss is catabolic and hard on skin, joints and gut, and KLOW is meant to offset that. Retatrutide does the fat loss; KLOW does nothing for it.

References

Sources

Educational information only, not medical advice. Talk to a licensed clinician before starting, changing, or stopping anything.